Abbott Laboratories stock page - price, fundamentals, dividends - iOCharts

Ticker
ABT

Price
110.22
Stock movement up
+1.57 (1.45%)
Company name
Abbott Laboratories
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
192.99B
Ent value
223.69B
Price/Sales
4.34
Price/Book
-
Div yield
1.71%
Div growth
11.60%
Growth years
8
FCF payout
37.48%
Trailing P/E
24.98
Forward P/E
22.54
PEG
2.17
EPS growth
12.40%
1 year return
-4.93%
3 year return
9.27%
5 year return
17.85%
10 year return
13.97%
Last updated: 2022-07-01

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.88
Dividend yield1.71%
Payout frequencyQuarterly
Maximum yield2.29%
Average yield1.67%
Minimum yield1.29%
Discount to avg yield1.97%
Upside potential2.01%
Yield as % of max yield74.41%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.71%
Current yield distribution36.67%
Yield at 100% (Min)1.29%
Yield at 90%1.45%
Yield at 80%1.50%
Yield at 50% (Median)1.64%
Yield at 20%1.84%
Yield at 10%1.96%
Yield at 0% (Max)2.29%

Dividend per share

Loading...
Dividend per share data
Years of growth8 years
CCC statusDividend Challenger
Dividend per share1.88
Payout frequencyQuarterly
Ex-div date14 Jul 2022
EPS (TTM)-
EPS (1y forward)4.89
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
ABTS&P500
DGR MR4.44%15.44%
DGR TTM8.77%7.80%
DGR 3 years17.13%3.88%
DGR 5 years11.60%4.73%
DGR 10 years7.18%8.30%
DGR 15 years8.16%5.82%
Time since last change announced206 days
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM31.09%37.48%
Average--
Forward38.45%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E24.98
Price to OCF24.44
Price to FCF30.12
Price to EBITDA21.05
EV to EBITDA24.39

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.34
Price to Book-
EV to Sales5.03

FINANCIALS

Per share

Loading...
Per share data
Current share count1.75B
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)44.51B
Gross profit (TTM)25.39B
Operating income (TTM)9.23B
Net income (TTM)7.72B
EPS (TTM)-
EPS (1y forward)4.89

Margins

Loading...
Margins data
Gross margin (TTM)57.04%
Operating margin (TTM)20.73%
Profit margin (TTM)17.35%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash7.67B
Net receivables7.18B
Total current assets23.43B
Goodwill23.18B
Intangible assets12.22B
Property, plant and equipment19.52B
Total assets74.01B
Accounts payable4.76B
Short/Current long term debt17.09B
Total current liabilities12.65B
Total liabilities38.38B
Shareholder's equity0.00
Net tangible assets8.64B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)7.90B
Capital expenditures (TTM)1.49B
Free cash flow (TTM)6.41B
Dividends paid (TTM)2.40B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open108.21
Daily high110.47
Daily low107.67
Daily Volume2.38M
All-time high141.46
1y analyst estimate139.85
Beta0.72
EPS (TTM)-
Dividend per share1.88
Ex-div date14 Jul 2022
Next earnings date20 Jul 2022

Downside potential

Loading...
Downside potential data
ABTS&P500
Current price drop from All-time high-22.08%-20.19%
Highest price drop-46.27%-56.47%
Date of highest drop23 Jul 20029 Mar 2009
Avg drop from high-11.24%-11.36%
Avg time to new high19 days12 days
Max time to new high1275 days1805 days
COMPANY DETAILS
ABT (Abbott Laboratories) company logo
Marketcap
192.99B
Marketcap category
Large-cap
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Employees
113000
SEC filings
CEO
Robert Ford
Country
USA
City
Abbott Park
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Abbott (ABT) closed at $110.22 in the latest trading session, marking a +1.45% move from the prior day.
July 1, 2022
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) and Intuit Inc. (INTU).
July 1, 2022
(Bloomberg) -- Meiji Holdings Co. plans to enter the $5.9 billion US baby formula market, joining Nestle SA, Danone DA and other global giants seeking to supply powdered milk to ease a national shorta...
July 1, 2022
In the face of significant economic, social and health-related challenges around the world, corporate sustainability has never been more important.
June 30, 2022
You'll make a lot more money if you know how to find and keep dividend payers in your portfolio.
June 30, 2022
Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top...
June 30, 2022
After five years of talks with American regulators, British infant formula maker Kendal Nutricare finally began shipping to the US this month — but only after a national shortage forced Washington to ...
June 30, 2022
Abbott (ABT) closed the most recent trading day at $109.10, moving +1.99% from the previous trading session.
June 29, 2022
ESLOY vs. ABT: Which Stock Is the Better Value Option?
June 29, 2022
Abbott (NYSE: ABT) will announce its second-quarter 2022 financial results on Wednesday, July 20, 2022, before the market opens.
June 29, 2022
Next page